Registry for patients undergoing angioplasty in Korea
Official title: KOMATE Registry: Korean Multicenter Angioplasty Team
Run by Yonsei University · NCT03908463 · Data updated 2026-11-12
This study is collecting information from patients who have had angioplasty to help understand how well the treatment works in real life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | October 5, 2018 |
| Main results expected | April 2039 |
| Study ends | April 2039 |
| Registry record updated | March 19, 2024 |
| Trial ID | NCT03908463 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are patients over 19 years old who are undergoing percutaneous coronary intervention.
✕Probably not a fit
Patients who refuse to participate or are pregnant will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data from patients who have undergone percutaneous coronary intervention (PCI) for conditions such as coronary artery disease and myocardial infarction. It aims to gather demographic, clinical, and procedural information, as well as clinical outcomes, to better understand real-world practices and results. The data will be collected through case report forms to ensure comprehensive documentation of each patient's experience. This observational approach allows for the analysis of treatment effectiveness in a diverse patient population.
Why it matters
Potential benefit: If successful, this registry could improve patient outcomes by providing insights into the effectiveness of PCI and informing best practices.
How similar studies have gone: Other observational registries have shown success in improving clinical practices and outcomes in similar patient populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Patients older than 19 years * 2\. Patients who undergo percutaneous coronary intervention Exclusion Criteria: * 1\. Refuse to participate * 2\. Pregnant women or women with potential childbearing
Where it's running
-
Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu 120-752 Seoul, South Korea
Seoul, South Korea Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry collecting data on patients undergoing heart artery procedures
This study is collecting information from patients who are having heart artery procedures to see how they do during and after their treatment.
-
Comparing a new medication to standard treatment for preventing stomach issues in heart patients on blood thinners
This study is testing a new medication called tegoprazan to see if it can prevent stomach problems just as well as the standard treatment for heart patients who are taking blood thinners.
-
Understanding sex hormones and inflammation in heart disease
This study looks at how sex hormones and inflammation affect heart disease in women to better understand their unique risks and improve treatment.
-
Investigating risk factors in patients with acute coronary syndrome undergoing a procedure
This study is trying to find out what risk factors affect patients with acute coronary syndrome who are having a heart procedure and how these factors relate to their health outcomes over two years.
-
Guiding NOAC therapy for patients with acute coronary syndrome after heart procedures
This study is testing a new combination of heart medications to see if it can help people with acute coronary syndrome avoid serious heart problems without causing more bleeding than standard treatment.
-
Optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI
This study is testing whether a new blood-thinning treatment for patients with atrial fibrillation undergoing heart procedures is safer and just as effective as the traditional approach that includes more medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.